- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07673757
Therapeutic Touch for Intramuscular Injection Pain
24. juni 2026 opdateret af: Gülistan YURDAGÜL, Kilis 7 Aralik University
Effect of Therapeutic Touch on Intramuscular Injection Pain: A Randomized Controlled Trial
The purpose of this study is to evaluate the effect of therapeutic touch on pain intensity associated with intramuscular injection and to examine the relationship between fear of pain and injection-related pain.
Participants are assigned to either a therapeutic touch group or a control group.
Pain intensity is assessed using a Visual Analog Scale (VAS), and fear of pain is assessed using the Fear of Pain Questionnaire.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
60
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Kilis
-
Kilis, Kilis, Tyrkiet (Türkiye), 79000
- Kilis 7 Aralık University, School of Health Services
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Being between 18 and 60 years of age,
- Being literate,
- Being able to complete the Fear of Pain Questionnaire (FPQ) without missing items,
- Having no known allergy or contraindication to pheniramine hydrogen maleate,
- Not having lower respiratory tract disease/asthma and not being in pregnancy or lactation period,
- Having normal consciousness (adequate orientation and ability to follow commands),
- Not having a severe mood disorder.
Exclusion Criteria:
- Incomplete completion of the questionnaire/scale during the study,
- Having medical conditions that may affect pain perception, such as peripheral vascular disease, peripheral neuropathy, or diabetes.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Experimental: Therapeutic Touch
In the intervention group, a supportive touch intervention was applied during the intramuscular injection to provide emotional support to the patient.
Immediately before the injection, the researcher demonstrated the procedure to the patient's companion with a brief example and provided guidance on how the hand should be held.
During the injection, the companion held the patient's hand with both hands, offering a calm, silent, and supportive presence.
Throughout this process, the nurse was responsible only for administering the intramuscular injection and ensuring clinical safety; the nurse did not participate in the intervention.
After the injection was completed, the patient's pain level was assessed using the VAS scale based on self-report.
|
This intervention involves supportive hand-holding by the patient's companion during the intramuscular injection.
Immediately before the injection, the researcher briefly demonstrated to the companion how the hand should be held and provided simple guidance.
During the injection, the companion held the patient's hand with both hands, offering a calm, silent, and emotionally supportive presence.
The nurse was responsible only for administering the intramuscular injection and monitoring clinical safety; the nurse did not participate in the intervention itself.
After the injection, the patient's pain level was assessed using the VAS scale based on self-report.
Andre navne:
|
|
Ingen indgriben: Control Group
Participants in this group received no additional intervention; the intramuscular injection was administered in accordance with routine clinical practice.
After the injection was completed, the patient's pain level was assessed using the same VAS scale based on self-report, as in the intervention group.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Pain Intensity (VAS Score)
Tidsramme: Immediately after the intramuscular injection (within 2 minutes).
|
Immediately after the intramuscular injection (within 2 minutes).
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
3. maj 2024
Primær færdiggørelse (Faktiske)
30. september 2024
Studieafslutning (Faktiske)
30. september 2024
Datoer for studieregistrering
Først indsendt
18. november 2025
Først indsendt, der opfyldte QC-kriterier
24. juni 2026
Først opslået (Faktiske)
29. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
29. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
24. juni 2026
Sidst verificeret
1. november 2025
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- E.45023
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Supportive Hand-Holding
-
Sunnybrook Health Sciences CentreAfsluttet
-
Shanxi Provincial People's HospitalThe First Affiliated Hospital of Henan University of Science and Technology og andre samarbejdspartnereRekrutteringLevercirrhose | Portal hypertensionKina
-
National University Hospital, SingaporeNational University, Singapore; Agency for Science, Technology and ResearchAfsluttet
-
Istanbul Medipol University HospitalAfsluttet
-
Northwestern UniversityAfsluttetSlag | Hånd funktionForenede Stater
-
Kafrelsheikh UniversityRekrutteringRekonstruktion af horisontale rygdefekterEgypten
-
Kinetic MusclesNational Institute of Neurological Disorders and Stroke (NINDS); The Cleveland... og andre samarbejdspartnereAfsluttet
-
Northwestern UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Afsluttet
-
Tel Aviv UniversityAfsluttet
-
Corporación de Rehabilitación Club de Leones Cruz...University of Valladolid; Universidad de MagallanesAfsluttet